Combined modality therapy for exsudative form of age-related macular degeneration
Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy with Lucentis (20 patients). For both groups Photosen...
Main Authors: | М. V. Budzinskaya, I. V. Gurova, I. V. Schegoleva, V. B. Loschenov, S. А. Shevchik, S. G. Kuzjmin, G. N. Vorogtsov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
2013-03-01
|
Series: | Biomedical Photonics |
Subjects: | |
Online Access: | https://www.pdt-journal.com/jour/article/view/3 |
Similar Items
-
Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01) -
A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
by: Ramandeep Singh, et al.
Published: (2022-01-01) -
Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01) -
Role of ranibizumab in management of macular degeneration
by: Singh Rishi, et al.
Published: (2007-01-01) -
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
by: Azad Rajvardhan, et al.
Published: (2007-01-01)